Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.51 |
| ▸ | CASP7 | P55210 | 2/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.50 |
| ▸ | ALB | P02768 | 1/20 | 0.50 |
| ▸ | HNF4A | P41235 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | MMP13 | P45452 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL296105 | 0.98 | ALDH1A1 (0.53) | ALDH1A1HSD17B10CASP7CASP1TDP1 | |
| SCHEMBL30640363 | 0.98 | ALDH1A1 (0.53) | ALDH1A1HSD17B10CASP7CASP1TDP1 | |
| SCHEMBL28269686 | 0.96 | ALDH1A1 (0.51) | ALDH1A1HSD17B10CASP7CASP1TDP1 | |
| SCHEMBL3176518 | 0.96 | ALDH1A1 (0.51) | ALDH1A1HSD17B10CASP7CASP1TDP1 | |
| SCHEMBL27321235 | 0.96 | ALDH1A1 (0.51) | ALDH1A1HSD17B10CASP7CASP1TDP1 | |
| SCHEMBL28269693 | 0.96 | ALDH1A1 (0.51) | ALDH1A1HSD17B10CASP7CASP1TDP1 | |
| Water SCHEMBL6715460 | 0.96 | ALDH1A1 (0.51) | ALDH1A1HSD17B10CASP7CASP1TDP1 | |
| Water SCHEMBL9316143 | 0.96 | ALDH1A1 (0.51) | ALDH1A1HSD17B10CASP7CASP1TDP1 | |
| Hydrazine SCHEMBL9315728 | 0.94 | HSD17B10 (0.54) | ALDH1A1HSD17B10CASP7CASP1TDP1 | |
| SCHEMBL10800198 | 0.93 | ALB (0.52) | ALDH1A1HSD17B10CASP7CASP1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116064025-A | Clean fracturing fluid thickener for low-permeability oil and gas field and preparation method thereof | 西安石油大学 | 2023-05-05 | — | — | CN | claimed |
| CN-116023926-A | Instant clean fracturing fluid thickener and preparation method thereof | 西安石油大学 | 2023-04-28 | — | — | CN | claimed |
| EP-0277273-A1 | Diazotype compositions | Andrews Paper and Chemical Co., Inc. (US) | 1988-08-10 | — | — | EP | claimed |
| US-4137972-A | Acidizing reservoirs while chelating iron with sulfosalicylic acid | SHELL OIL COMPANY (US) | 1979-02-06 | — | — | US | claimed |
| CN-116605893-B | Method for synthesizing ultrapure battery grade lithium carbonate by retired lithium battery | 赣州吉锐新能源科技股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-116605893-A | Method for synthesizing ultrapure battery grade lithium carbonate by retired lithium battery | 赣州吉锐新能源科技股份有限公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-116064025-A | Clean fracturing fluid thickener for low-permeability oil and gas field and preparation method thereof | 西安石油大学 | 2023-05-05 | — | — | CN | disclosed |
| US-11147881-B2 | Controlled drug release liposome compositions and methods thereof | TAIWAN LIPOSOME COMPANY, LTD. (TW) | 2021-10-19 | — | — | US | disclosed |
| CN-107681143-B | Nickel-cobalt lithium aluminate cathode material and preparation method thereof | 赣南师范大学 | 2020-04-21 | — | — | CN | disclosed |
| US-20190216932-A1 | CONTROLLED DRUG RELEASE LIPOSOME COMPOSITIONS AND METHODS THEREOF | TAIWAN LIPOSOME COMPANY, LTD. (TW) | 2019-07-18 | — | — | US | disclosed |
| US-10220095-B2 | Controlled drug release liposome compositions and methods thereof | TAIWAN LIPOSOME COMPANY, LTD (TW) | 2019-03-05 | — | — | US | disclosed |
| US-20170266295-A1 | CONTROLLED DRUG RELEASE LIPOSOME COMPOSITIONS AND METHODS THEREOF | TAIWAN LIPOSOME COMPANY, LTD. (TW) | 2017-09-21 | — | — | US | disclosed |
| CN-103696018-A | Novel fluorescent crystal material ammonium sulfosalicylate, and preparation and application thereof | FUJIAN MATTER STRUCTURE | 2014-04-02 | — | — | CN | disclosed |
| US-4167214-A | Process for stably sequestering iron while acidizing a reservoir | SHELL OIL COMPANY (US) | 1979-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10220095-B2 | Controlled drug release liposome compositions and methods thereof | LIPA, CEL, NPC1L1 | ALDH1A1 3968/4885HSD17B10 2246/4885CASP7 1011/4885 |
| US-11147881-B2 | Controlled drug release liposome compositions and methods thereof | LIPA, CEL, NPC1L1 | ALDH1A1 3968/4885HSD17B10 2246/4885CASP7 1011/4885 |
| US-20190216932-A1 | CONTROLLED DRUG RELEASE LIPOSOME COMPOSITIONS AND METHODS THEREOF | LIPA, CEL, NPC1L1 | ALDH1A1 3968/4885HSD17B10 2246/4885CASP7 1011/4885 |
| US-20170266295-A1 | CONTROLLED DRUG RELEASE LIPOSOME COMPOSITIONS AND METHODS THEREOF | LIPA, CEL, NPC1L1 | ALDH1A1 3968/4885HSD17B10 2246/4885CASP7 1011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.